drugset / Trial / NCT06617039

The Impact of Low-Dose Esketamine Combined With Ciprofol on the Quality of Early Postoperative Recovery Among Elderly Patients Undergoing Painless Gastroscopy

NCT06617039

Active not recruiting 376 enrolled Northern Jiangsu People's Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

To explore the impact of esketamine combined with ciprofol on the quality of early postoperative recovery in elderly patients undergoing painless gastroscopy, as well as the effectiveness and safety of this regimen.

Timeline

Start
2024-10-10
Primary completion
2025-07-15
Completion
2025-07-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified 0.3 mg/kg
Subject Esketamine Other / unclassified 0.5 mg/kg
Subject Remifentanil Small molecule 0.5 ug/kg
Comparator Cipepofol Small molecule 0.2 mg/kg
Comparator Cipepofol Small molecule 0.4 mg/kg

Indications

No indication recorded.